Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reiter

Showing results (361-370 of 426) with videos related to

Pageof 43
Sort By:
Blood|December 23, 1999
Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study GroupA Hochhaus, A Reiter, S Saussele, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|January 8, 2019
MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurementAmir Ishaq Khan, David A Reiter, Aarti Sekhar, et al.
Klinische Padiatrie|September 23, 1998
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trialsM Schrappe, A Reiter, G Henze, et al.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Leukemia|February 3, 2006
Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemiaO Maywald, M Pfirrmann, U Berger, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2008
Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonistsLawrence A Reiter, Christopher S Jones, William H Brissette, et al.
Physics in Medicine and Biology|November 19, 2003
Photoneutron yields from tungsten in the energy range of the giant dipole resonanceI Akkurt, J O Adler, J R M Annand, et al.
Leukemia|July 16, 2016
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosisM Jawhar, J Schwaab, D Hausmann, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of SmoothenedMichael J Munchhof, Qifang Li, Andrei Shavnya, et al.
Leukemia|September 13, 2003
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alphaU Berger, G Engelich, O Maywald, et al.
Pageof 43

Showing results (361-370 of 426) with videos related to

Sort By:
Pageof 43
Blood|December 23, 1999
Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study GroupA Hochhaus, A Reiter, S Saussele, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|January 8, 2019
MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurementAmir Ishaq Khan, David A Reiter, Aarti Sekhar, et al.
Klinische Padiatrie|September 23, 1998
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trialsM Schrappe, A Reiter, G Henze, et al.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Leukemia|February 3, 2006
Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemiaO Maywald, M Pfirrmann, U Berger, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2008
Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonistsLawrence A Reiter, Christopher S Jones, William H Brissette, et al.
Physics in Medicine and Biology|November 19, 2003
Photoneutron yields from tungsten in the energy range of the giant dipole resonanceI Akkurt, J O Adler, J R M Annand, et al.
Leukemia|July 16, 2016
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosisM Jawhar, J Schwaab, D Hausmann, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of SmoothenedMichael J Munchhof, Qifang Li, Andrei Shavnya, et al.
Leukemia|September 13, 2003
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alphaU Berger, G Engelich, O Maywald, et al.
Pageof 43